The BRAIN Conference | Two-day online conference
BRAIN has published landmark papers in clinical neurology and translational neuroscience since 1878. The Guarantors of BRAIN are devoted to promoting teaching, education & research in neurology and related disciplines.
BRAIN and its Guarantors are excited to announce a new venture: The BRAIN Conference! This two-day conference will feature a selection of fantastic speakers, invited by our conference Chairs from around the globe.
They will deliver clinical teaching talks and research presentations across the range of neurology, neuropsychiatry and neuroscience.
This conference will take place on March 4-5th 2021 and be fully online.
The following areas will be covered:
Cognitive Neurology (Chair: Masud Husain)
Epilepsy (Chair: Dimitri Kullman)
Neurodegenerative (Chair: Anne Rosser),
Neurogenetics (Chair: Nicholas Wood),
Headache (Chair: Peter Goadsby),
Traumatic Brain Injury (Chair: Dave Sharp),
Nerve (Chair: Mary Reilly),
Stroke (Chair: Hugh Markus),
Neuroinflammation/MS (Chair: Olga Ciccarelli),
Movement Disorders (Chair: Anette Schrag),
Infectious Disease (Chair: Tom Solomon),
Neuropsychiatry (Chair: Paul Fletcher),
COVID Neurology (Chair: Mike Zandi) and
Muscle (Chair: Mike Hanna)
There will also have short ‘data blitz’ presentations in these sessions – BRAIN encourages all early-career researchers to submit an abstract to be considered.
Abstract submission now open!
BRAIN is keen to make this conference accessible to all – registration is only GBP 10 [free if you cannot afford this].
Register Now
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.